Mack David Henry 4
4 · PMV Pharmaceuticals, Inc. · Filed Oct 29, 2025
Insider Transaction Report
Form 4
Mack David Henry
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2025-10-27−220,643→ 0 totalExercise: $1.37Exp: 2026-11-16→ Common Stock (220,643 underlying) - Exercise/Conversion
Common Stock
2025-10-27$1.37/sh+220,643$302,281→ 451,109 total
Holdings
- 165,307(indirect: See footnote)
Common Stock
- 453,582(indirect: See footnote)
Common Stock
- 56,978(indirect: See footnote)
Common Stock
Footnotes (6)
- [F1]Excludes 305,667 shares previously reported as held directly by the reporting person which were re-registered on August 13, 2025 and are now held of record by the Mack-Mulligan Revocable Trust (the "Revocable Trust").
- [F2]The shares are held of record by the Stinson 2021 Irrevocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
- [F3]Includes 305,667 shares previously reported as held directly by the reporting person which were re-registered on August 13, 2025 and are now held of record by the Revocable Trust.
- [F4]The shares are held of record by the Revocable Trust.
- [F5]The shares are held of record by the Mack/Mulligan 2020 Irrevocable Descendants' Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
- [F6]The shares subject to the option are fully vested and immediately exercisable.